VOYA Investment Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-14,107
Closed -$477K 2860
2021
Q2
$477K Buy
14,107
+810
+6% +$20.6K ﹤0.01% 2121
2021
Q1
$311K Buy
13,297
+11
+0.1% +$333 ﹤0.01% 2299
2020
Q4
$383K Buy
13,286
+3,125
+31% +$78.7K ﹤0.01% 2073
2020
Q3
$206K Buy
10,161
+792
+8% +$19.3K ﹤0.01% 2142
2020
Q2
$282K Sell
9,369
-57
-0.6% -$2.05K ﹤0.01% 2001
2020
Q1
$296K Buy
9,426
+1,809
+24% +$62.9K ﹤0.01% 1924
2019
Q4
$359K Buy
+7,617
New +$220K ﹤0.01% 2081

VOYA Investment Management's CNST Position: Q3 2021 in Review

VOYA Investment Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 14,107 shares — an estimated $477K sold.

VOYA Investment Management first reported a position in CNST in Q4 2019 and held it in 7 quarters. The position peaked at $477K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • VOYA Investment Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • VOYA Investment Management sold 14,107 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $477K.
  • VOYA Investment Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
  • VOYA Investment Management's Constellation Pharmaceuticals, Inc. position peaked at $477K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on VOYA Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.